Moreover, OAT-1746 treatment affects the expression of genes involved in leukocyte chemotaxis (Ccl2, Ccl7, Ccl17) and supporting glioma migration and invasion (Cme1, S100a4 and Mmp14). This evidence concerns the gene CCL17 and central nervous system cancer.